On April 25, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 25, Kenneth Walton Hitchner III increased its holdings at an average price of HK$0.8729 per share on April 10$CSTONE PHARMA-B (02616.HK)$90,500 common shares worth approximately HK$79,000. After the increase in holdings, Kenneth Walton Hitchner III's latest shareholding was 737,000 shares, and the good position ratio increased from 0.05% to 0.06%.
Additional information: Box 24: Number of shares and highest price has been evaluated. Boxes 25 & 26: Number of Shares and Percentage figures have been examined. Box 27: Number of shares has been discussed. Box 28: Such derivative amendments introduced the restricted shares units proposed and to be issued to Kenneth Walton Hitchner III proposed to the post-IPO RSU scheme proposed by cStone Pharmaceuticals.What is disclosure of interests?
As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. The directors and top executives of a listed company must disclose their interest in shares and debentures of the listed company and the company linked to the listed company.
Why is disclosure of interests important?
Disclosure of interests allows investors to identify (1) persons who control or are capable of controlling the stock interests of listed companies, and (2) persons who may benefit from transactions involving linked entities of listed companies.